A three-day accelerated management programme, designed specifically for pharmaceutical/ biotechnology professionals and also applicable to medical device/animal health industries, to give you the high-performance management skills of an MBA
14-16 May 2019
& 4-6 Nov 2019
GBP 1,799 1,499 *
EUR 2,519 2,099 *
USD 2,806 2,338 *
* When you book before 15 Mar
Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This course has been especially designed to help you transcend these challenges by training you to become equipped to see the bigger picture in all aspects of your role. It will help you build your management skills for the future and prepare you to fulfil your ambitions. The Pharma Mini MBA accelerated management programme is a distillation of the most valuable parts of an MBA, as applied to the pharmaceutical industry. It will provide you with practical management tools to apply in the workplace, as well as giving a real taste of an MBA course with the pharmaceutical case studies from business schools.
Pharmaceutical industry context – business school pharmaceutical case studies on each module
This intensive course will help you to translate your learning into new behaviours and improvements in your capability and performance and will work through live issues impacting on the industry and on you directly. The individual and group exercises will focus on pharmaceutical/biotech/ generic MBA case studies, and also on your own challenges and examples. The case studies will help give the ‘feel’ of a full MBA and help you understand more about the strategies used in today’s pharmaceutical and associated industries.
The Pharma Mini MBA is also an intensive guide to all that is ‘best and most practical’ on an MBA course – with specific focus on the pharmaceutical sector. It is also of value either to gain the most useful aspects of an MBA or as an MBA taster. It will provide a foundation of the essential MBA elements to apply directly to your role. The pharmaceutical industry requires employees within the industry to focus on successful leadership and business management skills, which this programme is designed to give you.
MBA learning style of the programme
The Pharma Mini MBA learning style is ‘hands-on’ rather than academic. The programme is very practical, without being too theoretical, with industry-relevant case studies drawn on from business school cases.
This intensive three-day course covers the key areas of an MBA and applies these MBA tools and concepts to the pharmaceutical industry, providing you with a firm foundation of the essential MBA thinking and terminology. Three modules will be covered in just three days of interactive workshops, to enhance the value of the course and, to minimise your time away from the office, there is also optional pre- and post-work set by the programme director.
A ‘must attend’ for professionals in the pharmaceutical/ biotech/medical device industries wishing to develop their business management skills for more senior levels and beyond mere technical skills. It will also help anyone thinking of studying for an MBA who would like an idea of what is involved. It is particularly beneficial to attend with a colleague to maximise the practical learning.
Introduction, welcome and key objectives of the course
Strategic thinking and applying this in the pharmaceutical industry
Commercial management and leadership in the pharmaceutical industry
- What are the core competencies of effective leaders?
- Leadership vs management
- Leadership style
Hot topics in market access
Leading change and project management in the pharmaceutical industry
- Diagnosis around change
- How to create the conditions for successful change
- Why people resist change and how to manage this
- Change management (pharmaceutical case study in leading a structural reorganisation)
- Creating a team, department and organisation relevant to today’s pharmaceutical business needs
- Team formation and development
- Project management tools and techniques to use in implementing pharmaceutical projects
- Applying key project management techniques to pharmaceutical projects
- How to manage in a matrix management environment
- Understanding of cultural awareness to work more effectively with pharmaceutical colleagues
Managing innovation in the pharmaceutical industry
h3. Pharma Mini MBA: Post-Course DevelopmentPractical application/review
Laura Brown (14-16 May 2019, 4-6 Nov 2019)
Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.
Nick Meadows (14-16 May 2019)
Nick Meadows has nearly 10 years of experience working in the life sciences industry as a management consultant, technology transfer analyst and medical research scientist. In 2016 he joined Strategy& (part of the PwC network) where he is supporting clients within the pharmaceutical industry address strategic and operational challenges in development and commercial functions.
As a consultant he has managed engagements across research and development and commercial functions of the life sciences and pharmaceutical industry. In the past 5 years his work has spanned major transformational projects in clinical operations and research and development, to asset level strategy through direct engagement with program teams and commercial leads. In his former role at Kinapse (2011 – 2016) he led the market access service line where he supported clients optimise pricing and reimbursement outcomes for launching and development products.
In addition he has collaborated with regulators, policy makers and healthcare practitioners to provide recommendations to accelerate the development of personalised medicines. He has also developed a deep understanding of the biosimilars landscape.
He holds an MBA from Saïd Business School, University of Oxford, and a PhD and BSc (Hons) in Molecular Biology from University of Queensland, Brisbane, Australia.
| 14-16 May 2019 | ||||
| 14-16 May 2019 | Rembrandt Hotel, London | GBP 1,799.00 EUR 2,519.00 USD 2,806.00 + VAT @ 20.00% |
GBP 1,499.00 EUR 2,099.00 USD 2,338.00 Until 15 Mar |
Enrol now |
| 4-6 Nov 2019 | ||||
| 4-6 Nov 2019 | Rembrandt Hotel, London | GBP 1,799.00 EUR 2,519.00 USD 2,806.00 + VAT @ 20.00% |
Enrol now | |
“Laura [was] very engaging, varied content, good level, Not one boring moment! Deming [offered a] good practical experience in pharma. Great to have had a chance to practically use the tools Laura recommended. ”
Emma Dupree, Associate Director, Compliance, AbbVie
“Great energy. Best training I had in a long time. ”
Florent Noel, Sr Manager QA, Covis Pharma
“Overall good, too little time!”
Janni Hermansen, Senior PV Advisor, LEO Pharma
“Laura is a very dynamic person that knows very well how to deliver a message. The topics are very interesting from the pharma/management point of view and articulated
- Would be interesting to have topic about pharma at geographical level”
Janneth Ospina Paladines, Senior Regulatory Affairs Associate, Gilead Sciences International
“Really good overview and opportunity to ask many questions. Great course.”
Luisa Teixeira, Account Manager, Owen Mumford Ltd
“Very interesting”
Emine Akin, Marketing & Sales Junior Assistant, Chiesi Group
“The course is very good. Gives you in three days an overall view on core subjects that management people need to know to improve. Case studies were excellent and realistic. Speakers were great ”
Diana Binkert, , Acino International AG
“Course was very condensed either reduce the content or extend the course days”
Aziz-ul-Islam Chaudhry, Head of Regulatory Affairs, Martindale Pharma
“I found it really practical, lively with possibility to exchange experiences”
Mireille Pierrevelcin, Export Area Manager, Cesra Arzneimittel GmbH & Co
“Overall excellent course, very well organized. Suitable content, stimulating presentations and excellent speakers.”
Suna Horner, Associate Medical Manager, HRA Pharma UK & Ireland Ltd
“It was a very nice overview on MBA topics overview on MBA topics with a great speaker and interesting discussions”
Ricarda Tiemeyer, Drug Safety Scientist & Deputy LSR, Roche Pharma (Switzerland) AG
“Excellent. Thoroughly enjoyed it and left feeling like I had learnt something, which, at the end of the day, is the primary goal. I appreciated the method of teaching and enjoyed meeting other people on the course.”
Zain Masters, Business Development & Licensing Director, Masters Speciality Pharma
“Provided exactly what I required”
Peter Gaines, Chief Medical Officer, Veryan Medical Limited
“It exceeded my expectations. Really enjoyed practical sessions and focused environment.”
Andriy Kirmach, Associate Director, International Compliance & Ethics, Allergan
“It was very informative and engaging with real potential to help with daily practicalities. The full content and delivery is hitting the mark in my opinion.”
Irem Bostanci, Account Manager OEM, Owen Mumford Ltd
“An excellent course. I would recommend to all wanting a flavour of an MBA.”
Bindu Patel, Senior Manager , Sanofi Pasteur MSD
“Good mix of people and perspectives; venue was easy to get to. Guest speakers were a good idea.”
Julie-Anne Webb, Inside Sales Associate - EU, Core Informatics
“Few topics to develop”
Edmondo Corona, Plan Engineering Director, AbbVie
“Good”
Kevin Polhill, Quality and Regulatory Compliance Specialist, Invicta Compliance
“This was a well-organised course and both the content and speakers were very good. I do think that the topics could have been tied together better in some instances in the same way as the strategy tools we covered. Some elements such as project management were covered far too quickly to be of any use. ”
Emma Woods, Pharmaceutical Development Innovation Lead, AstraZeneca Pharmaceuticals Development
“Excellent trainer, lots of info in a short time but actually by the end I thought it was a suitable duration and speed. Would have been nicer to have a little more on the PM part at the end simply because that fits better with my role.”
Julia Caldwell, Clinical Trial Manager, Allergan
“It was rushed in places with things being skipped over - its good to try and include a lot but not if its skipped...doesn't help ”
GEOF WOLFENDEN, IP & Contracts Manager, AstraZeneca
“Perfect blend of theory and practicality that allowed the attendees to process and apply the information to real world scenarios. Extremely valuable taster into the world and benefits of an MBA!”
Dave Wood, Account Director, PharmiWeb Solutions